Lacosamide

Overview

Lacosamide is an antiepileptic drug used primarily to treat partial-onset seizures. It works by selectively enhancing slow inactivation of voltage-gated sodium channels, thereby stabilizing hyperexcitable neuronal membranes.

API suppliers (12)

Suppliers of Lacosamide backed by a verifiable FDA Type II Drug Master File. Source: FDA quarterly DMF list.

• INDOCO REMEDIES LTD2 active DMF
• Beijing SL Pharmaceutical Co., Ltd.China2 active DMF
• MSN PHARMACHEM PRIVATE LTD2 active DMF
• DPT Laboratories, Ltd.United States1 active DMF
• Ono Pharmaceutical Co., Ltd.Japan1 active DMF
• DPT Laboratories, Ltd.United States1 active DMF
• Hetero Drugs LimitedIndia1 active DMF
• Alembic Pharmaceuticals LimitedIndia1 active DMF
• Zydus Lifesciences LimitedIndia1 active DMF
• SYMPHONY PHARMA LIFESCIENCES PRIVATE LTD1 active DMF
• Dr. Reddy's Laboratories Ltd.India
• LUPIN MANUFACTURING SOLUTIONS LTD

Patent & exclusivity (US)

Per the FDA Orange Book (81 approved US products), the latest listed US patent on Lacosamide expires 4 Jun 2040 and exclusivity 27 Apr 2026. Generic API sourcing typically opens up once these lapse.

Therapeutic areas